Table 2.
The patients administered chemotherapy regimens
| Combination drug | Number of patients |
|---|---|
| Gem – CDDP | 14(63.6%) |
| BEP | 2(9.1%) |
| Others* | 6(27%) |
| Total number of cycles administered, median (range) | 5 (1-6) |
| Three cycles or less | 5 (22.7%) |
| Four cycles | 4(22.7%) |
| Five cycles | 2(9.1%) |
| Six cycles | 10(45.5%) |
| Total dose of CDDP (mg/m2) Median ± SEM (Range) |
465±42.63 (140-870) |
| Previous treatment with chemotherapy | Yes: 9 (40.9%) No: 13 (59.1%) |
Gem-CDDP: Gemcitabine-Cisplatin, BEP: Cisplatin - Bleomycin – Etoposide,
*
Agents combined with Cisplatin: Cytosar, Etoposide, Adriamycin, Cyclophosphamide, Taxol, Xeloda, Epirabicin, 5-Fluorouracil (5-FU)